Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer

Cell origin of BRCA2-mutant breast cancer

Nature Cell Biology volume 26, pages 43–44 (2024)Cite this article

Subjects

The different compartments of the mammary stem cell hierarchy develop into distinct breast cancer subtypes as a result of specific genetic lesions. A recent study identifies aberrant ERBB3low luminal progenitors with altered proteostasis and translation as the cell of origin of BRCA2-mutant breast cancer.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: A normal mammary cell hierarchy may develop into distinct breast tumour subtypes.

References

  1. Visvader, J. E. Nature 469, 314–322 (2011).

    Article  CAS  PubMed  Google Scholar 

  2. Kuchenbaecker, K. B. et al. JAMA 317, 2402–2416 (2017).

    Article  CAS  PubMed  Google Scholar 

  3. Molyneux, G. et al. Cell Stem Cell 7, 403–417 (2010).

    Article  CAS  PubMed  Google Scholar 

  4. Joyce, R. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-023-01315-5 (2024).

    Article  PubMed  Google Scholar 

  5. Nolan, E. et al. Nat. Med. 22, 933–939 (2016).

    Article  CAS  PubMed  Google Scholar 

  6. Balko, J. M. et al. Proc. Natl Acad. Sci. USA 109, 221–226 (2012).

    Article  CAS  PubMed  Google Scholar 

  7. Saxton, R. A. & Sabatini, D. M. Cell 168, 960–976 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Karaayvaz-Yildirim, M. et al. Sci. Adv. 6, eaay2611 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Liu, G. Y. & Sabatini, D. M. Nat. Rev. Mol. Cell Biol. 21, 183–203 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Hua, H. et al. J. Hematol. Oncol. 12, 71 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Cancer Institutes, State Key Laboratory of Genetic Engineering, Key Laboratory of Breast Cancer in Shanghai, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

    Jiahui Xu & Suling Liu

  2. The Shanghai Key Laboratory of Medical Epigenetics, Shanghai, China

    Suling Liu

  3. Shanghai Key Laboratory of Radiation Oncology, Shanghai, China

    Suling Liu

Authors
  1. Jiahui Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Suling Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Suling Liu.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Xu, J., Liu, S. Cell origin of BRCA2-mutant breast cancer. Nat Cell Biol 26, 43–44 (2024). https://doi.org/10.1038/s41556-023-01322-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41556-023-01322-6

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer